TargetTransient receptor potential cation channel subfamily M member 4(Homo sapiens)
Turning Point Therapeutics
Curated by ChEMBL
Turning Point Therapeutics
Curated by ChEMBL
Affinity DataEC50: 589nMAssay Description:Agonist activity at human TRPM4 expressed in CHO-K1 cells assessed as increase in relative fluorescence unit by measuring membrane potential by FLIPR...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily M member 4(Homo sapiens)
Turning Point Therapeutics
Curated by ChEMBL
Turning Point Therapeutics
Curated by ChEMBL
Affinity DataEC50: 1.35E+3nMAssay Description:Agonist activity at human TRPM4 expressed in CHO-K1 cells assessed as increase in relative fluorescence unit by measuring membrane potential by FLIPR...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily M member 4(Homo sapiens)
Turning Point Therapeutics
Curated by ChEMBL
Turning Point Therapeutics
Curated by ChEMBL
Affinity DataEC50: 1.70E+3nMAssay Description:Agonist activity at human TRPM4 expressed in CHO-K1 cells assessed as increase in relative fluorescence unit by measuring membrane potential by FLIPR...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily M member 4(Homo sapiens)
Turning Point Therapeutics
Curated by ChEMBL
Turning Point Therapeutics
Curated by ChEMBL
Affinity DataEC50: 1.82E+3nMAssay Description:Agonist activity at human TRPM4 expressed in CHO-K1 cells assessed as increase in relative fluorescence unit by measuring membrane potential by FLIPR...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily M member 4(Homo sapiens)
Turning Point Therapeutics
Curated by ChEMBL
Turning Point Therapeutics
Curated by ChEMBL
Affinity DataEC50: 3.16E+3nMAssay Description:Agonist activity at human TRPM4 expressed in CHO cells assessed as increase in A23187-induced intracellular calcium level by FLIPR assayMore data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily M member 4(Homo sapiens)
Turning Point Therapeutics
Curated by ChEMBL
Turning Point Therapeutics
Curated by ChEMBL
Affinity DataEC50: 8.91E+3nMAssay Description:Agonist activity at human TRPM4 expressed in CHO-K1 cells assessed as increase in relative fluorescence unit by measuring membrane potential by FLIPR...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily M member 4(Homo sapiens)
Turning Point Therapeutics
Curated by ChEMBL
Turning Point Therapeutics
Curated by ChEMBL
Affinity DataEC50: 1.14E+4nMAssay Description:Agonist activity at human TRPM4 expressed in CHO-K1 cells assessed as increase in relative fluorescence unit by measuring membrane potential by FLIPR...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily M member 4(Homo sapiens)
Turning Point Therapeutics
Curated by ChEMBL
Turning Point Therapeutics
Curated by ChEMBL
Affinity DataEC50: 1.15E+4nMAssay Description:Agonist activity at human TRPM4 expressed in CHO-K1 cells assessed as increase in relative fluorescence unit by measuring membrane potential by FLIPR...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily M member 4(Homo sapiens)
Turning Point Therapeutics
Curated by ChEMBL
Turning Point Therapeutics
Curated by ChEMBL
Affinity DataEC50: 2.45E+4nMAssay Description:Agonist activity at human TRPM4 expressed in CHO-K1 cells assessed as increase in relative fluorescence unit by measuring membrane potential by FLIPR...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily M member 4(Homo sapiens)
Turning Point Therapeutics
Curated by ChEMBL
Turning Point Therapeutics
Curated by ChEMBL
Affinity DataEC50: 2.57E+4nMAssay Description:Agonist activity at human TRPM4 expressed in CHO-K1 cells assessed as increase in relative fluorescence unit by measuring membrane potential by FLIPR...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily M member 4(Homo sapiens)
Turning Point Therapeutics
Curated by ChEMBL
Turning Point Therapeutics
Curated by ChEMBL
Affinity DataEC50: 2.63E+4nMAssay Description:Agonist activity at human TRPM4 expressed in CHO-K1 cells assessed as increase in relative fluorescence unit by measuring membrane potential by FLIPR...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily M member 4(Homo sapiens)
Turning Point Therapeutics
Curated by ChEMBL
Turning Point Therapeutics
Curated by ChEMBL
Affinity DataEC50: <6.31E+4nMAssay Description:Agonist activity at human TRPM4 expressed in CHO cells assessed as increase in A23187-induced intracellular calcium level by FLIPR assayMore data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily M member 4(Homo sapiens)
Turning Point Therapeutics
Curated by ChEMBL
Turning Point Therapeutics
Curated by ChEMBL
Affinity DataEC50: <6.31E+4nMAssay Description:Agonist activity at human TRPM4 expressed in CHO cells assessed as increase in A23187-induced intracellular calcium level by FLIPR assayMore data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily M member 4(Homo sapiens)
Turning Point Therapeutics
Curated by ChEMBL
Turning Point Therapeutics
Curated by ChEMBL
Affinity DataEC50: <6.31E+4nMAssay Description:Agonist activity at human TRPM4 expressed in CHO cells assessed as increase in A23187-induced intracellular calcium level by FLIPR assayMore data for this Ligand-Target Pair